Personalizing the treatment of head and neck cancer in vitro: The 3D-OTC model
Fabian Stögbauer(Technical University of Munich), Barbara Wollenberg(TUM Klinikum), Johannes Wirth(Technical University of Munich), Benedikt Schmidl(Klinik und Poliklinik für Hals-, Nasen-, Ohrenheilkunde), Luca Engelmann(Technical University of Munich), Ali Bashiri Dezfouli(Technical University of Munich), Nicole Strittmatter(Robert Bosch (Germany)), Melanie Boxberg(Starnberg Hospital), Carolin Mogler(Technical University of Munich), Tobias Weiser(Technical University of Munich), Katharina Pigorsch(Technical University of Munich), Katja Steiger(Technical University of Munich), Jan Budczies(German Cancer Research Center), Iordanis Ourailidis(Heidelberg University)
Cited by 0
Related Papers
Standardized evaluation of tumor-infiltrating lymphocytes in breast cancer: results of the ring studies of the international immuno-oncology biomarker working group
|Modern Pathology|2016|281
Tumour budding activity and cell nest size determine patient outcome in oral squamous cell carcinoma: proposal for an adjusted grading system
|Histopathology|2017|105
PD-L1 and PD-1 and characterization of tumor-infiltrating lymphocytes in high grade sarcomas of soft tissue – prognostic implications and rationale for immunotherapy
|OncoImmunology|2017|89
Composition and Clinical Impact of the Immunologic Tumor Microenvironment in Oral Squamous Cell Carcinoma
|The Journal of Immunology|2018|81
Introducing a novel highly prognostic grading scheme based on tumour budding and cell nest size for squamous cell carcinoma of the uterine cervix
|The Journal of Pathology Clinical Research|2018|80